When administered concomitantly with alcohol, loratadine has no potentiating effects as measured by psychomotor performance studies.
Potential interaction may occur with all known inhibitors of CYP3A4 or CYP2D6 resulting in elevated levels of loratadine (see Pharmacology: Pharmacokinetics under Actions), which may cause an increase in adverse events.